Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Neil A Lachant"'
Publikováno v:
ERJ Open Research, Vol 7, Iss 1 (2021)
There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this observational study, patients were followed up after intermediate- or high-risk pulmonary embolism
Externí odkaz:
https://doaj.org/article/b65d71a060b640929c49d0c93e69d468
Publikováno v:
Journal of Vascular Surgery Cases and Innovative Techniques, Vol 7, Iss 4, Pp 605-609 (2021)
A variable clinical presentation is emerging as a hallmark of the novel SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). In addition to hypoxic respiratory failure, multiorgan dysfunction, and septic shock, significant thromboembolic com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3b155e52f1da63b9fd5014da3e2a1b8
http://www.sciencedirect.com/science/article/pii/S2468428721001350
http://www.sciencedirect.com/science/article/pii/S2468428721001350
Autor:
Stephen Rappaport, Daniel J. Lachant, Paritosh Prasad, Peter Kouides, Neil A. Lachant, R. James White
Publikováno v:
Journal of Thrombosis and Haemostasis
Background Thrombotic disease complicates severe SARS-CoV-2 infection and is associated with increased morbidity and mortality Various anticoagulation strategies have been evaluated in hospitalized patients to prevent complications The impact of chro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abc7518e115cb92384ed99bbd36958cb
https://doi.org/10.1111/jth.15032
https://doi.org/10.1111/jth.15032
Publikováno v:
TP51. TP051 COVID: LUNG INFECTION, MULTIORGAN FAILURE, AND CARDIOVASCULAR.
Rationale: SARS-CoV-2 has been associated with increased risk for thrombotic disease and respiratory failure. Therapeutic or intermediate dose anticoagulation has been associated with decreased thrombotic events and potentially improved hospital outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5b6178782b81883840ab66dcd960a5bf
https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2625
https://doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2625
Autor:
Neil A. Lachant, Daniel J. Lachant, Stephen Rappaport, Paritosh Prasad, R. James White, Dominick Roto
Publikováno v:
Thrombosis Research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ac1d2ca2309a0a2688320973b362aa9
https://pubmed.ncbi.nlm.nih.gov/34246012
https://pubmed.ncbi.nlm.nih.gov/34246012
Publikováno v:
Respiratory medicine. 187
Background Pulmonary embolism (PE) response teams (PERT) have been developed to improve in-hospital mortality. Identifying intermediate risk PE patients that will progress despite anticoagulation is difficult, especially because outcomes with modern
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3287987407b35223bbc0d0fca48eed57
https://pubmed.ncbi.nlm.nih.gov/34416617
https://pubmed.ncbi.nlm.nih.gov/34416617
Publikováno v:
ERJ Open Research
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 1 (2021)
article-version (VoR) Version of Record
ERJ Open Research, Vol 7, Iss 1 (2021)
There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this observational study, patients were followed up after intermediate- or high-risk pulmonary embolism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9b4f39852944e5a1c459325c218e24a
http://europepmc.org/articles/PMC7861033
http://europepmc.org/articles/PMC7861033
Autor:
Neil A Lachant, Geoffrey Newcomb, Daniel J. Lachant, Bruce I. Goldman, Bennett L. Wilson, R. James White
Publikováno v:
Cardiovascular Pathology. 57:107392
Introduction Response to anticoagulation varies during management of acute hospitalized pulmonary embolism. We aimed to study thrombus histology in pulmonary embolism samples removed during acute surgical embolectomy to evaluate whether thrombus morp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18985439eb3772e00bd3a9205722a64f
https://doi.org/10.1016/j.carpath.2021.107392
https://doi.org/10.1016/j.carpath.2021.107392
Autor:
R. James White, Bruce I. Goldman, Scott J. Cameron, Vaseem U. Chengazi, Daniel J. Lachant, Christina Bach, Bennett L. Wilson, Anthony P. Pietropaoli, Neil A. Lachant
Publikováno v:
Pulmonary Circulation
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation, Vol 10 (2020)
Long-term outcomes after acute pulmonary embolism vary from complete resolution to chronic thromboembolic pulmonary hypertension (CTEPH). Guidelines after acute pulmonary embolism are generally limited to anticoagulation duration. We assessed patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b447f6d96cfaa3c1107ae01153893a5
https://pubmed.ncbi.nlm.nih.gov/33014336
https://pubmed.ncbi.nlm.nih.gov/33014336
Autor:
Peter A. Kouides, Edward P. Calomeni, William T. Gunning, Neil A. Lachant, Mary R. Smith, James N. Turner, Shantala Roysam, Bodri Roysam, Meera Raghavan
Publikováno v:
Journal of Clinical Medicine
Journal of Clinical Medicine, Vol 9, Iss 1734, p 1734 (2020)
Volume 9
Issue 6
Journal of Clinical Medicine, Vol 9, Iss 1734, p 1734 (2020)
Volume 9
Issue 6
One thousand and eighty patients, having prolonged bleeding times, frequent epistaxis, menorrhagia or easy bruising or other bleeding manifestations, and excluding those with von Willebrand&rsquo
s disease, were evaluated for platelet dense gran
s disease, were evaluated for platelet dense gran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aa2da9622304e65d70a83e7464edec9
https://doi.org/10.3390/jcm9061734
https://doi.org/10.3390/jcm9061734